Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 6/20 | 0.45 |
| ▸ | NCF1 | P14598 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | MAX | P61244 | 1/20 | 0.41 |
| ▸ | ACP1 | P24666 | 2/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3281012 | 0.78 | CHEK1 (0.47) | ALDH1A1KDM4EPOLBGAAACP1 | |
| SCHEMBL5344059 | 0.75 | ALDH1A1 (0.48) | ALDH1A1KDM4EGAAACP1HIF1A | |
| SCHEMBL5332652 | 0.74 | MYC (0.58) | TOP2AKDM1AALDH1A1KDM4EPOLB | |
| SCHEMBL483522 | 0.74 | MYC (0.41) | TOP2AALDH1A1KDM4EPOLBMYC | |
| SCHEMBL13367603 | 0.71 | NCF1 (0.54) | NCF1ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL29581869 | 0.70 | MAPT (0.56) | ALDH1A1KDM4EPOLBGAAMYC | |
| SCHEMBL7912388 | 0.70 | MAPT (0.56) | ALDH1A1KDM4EPOLBGAAMYC | |
| SCHEMBL732274 | 0.70 | MAPT (0.56) | ALDH1A1KDM4EPOLBGAAMYC | |
| SCHEMBL9340104 | 0.70 | GAA (0.52) | NCF1ALDH1A1KDM4EGAANQO2 | |
| SCHEMBL20548494 | 0.69 | CYP1A2 (0.39) | KDM1AALDH1A1KDM4EGAAACP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12297221-B2 | Functionalization and purification of molecules by reversible group exchange | ILLUMINA, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-20240384262-A1 | LINKING SEQUENCE READS USING PAIRED CODE TAGS | ILLUMINA, INC. | 2024-11-21 | — | — | US | disclosed |
| US-11993772-B2 | Linking sequence reads using paired code tags | ILLUMINA, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-20230406874-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | ILLUMINA, INC. | 2023-12-21 | — | — | US | disclosed |
| US-11760772-B2 | Functionalization and purification of molecules by reversible group exchange | ILLUMINA, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20210277043-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | ILLUMINA, INC. (US) | 2021-09-09 | — | — | US | disclosed |
| US-11021504-B2 | Functionalization and purification of molecules by reversible group exchange | ILLUMINA, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| US-11008567-B2 | Oligonucleotide replacement for di-tagged and directional libraries | ILLUMINA, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| EP-3722423-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | Illumina, Inc. (US) | 2020-10-14 | — | — | EP | disclosed |
| EP-2739732-B1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | ILLUMINA INC (US) | 2020-04-22 | — | — | EP | disclosed |
| US-4281061-A | DETECTABLE SIGNAL FROM FLUORESCENT DYE OR LABELED ENZYME | SYVA COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4275149-A | IMMUNOASSAY | SYVA COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4272506-A | BINDING A LABELED MEMBER OF A SPECIFIC BINDING PAIR TO A MERCAPTO-ACTIVATED SUPPORT THROUGH CLEAVABLE DISULFIDE LINKAGES; IMMUNOASSAY; ACCURACY | SYVA COMPANY (US) | 1981-06-09 | — | — | US | disclosed |
| US-4256834-A | REPRESSING THE SIGNALS PRODUCED BY UNBOUND LABELS; SENSITIVITY | SYVA COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| EP-0022768-A1 | MACROMOLECULAR ENVIRONMENT CONTROL IN SPECIFIC RECEPTOR ASSAYS. | SYVA CO (US) | 1981-01-28 | — | — | EP | disclosed |
| EP-0017908-A1 | A method for determining the presence in a sample of an analyte and a kit for use in this method | SYVA COMPANY (US) | 1980-10-29 | — | — | EP | disclosed |
| EP-0015695-A1 | Support-ligand analog-fluorescer conjugate and serum assay method involving such conjugate | SYVA COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| EP-0022768-A4 | MACROMOLECULAR ENVIRONMENT CONTROL IN SPECIFIC RECEPTOR ASSAYS. | SYVA CO (US) | 1980-08-18 | — | — | EP | disclosed |
| US-4193983-A | Labeled liposome particle compositions and immunoassays therewith | SYVA COMPANY (US) | 1980-03-18 | — | — | US | disclosed |
| WO-1979000882-A1 | MACROMOLECULAR ENVIRONMENT CONTROL IN SPECIFIC RECEPTOR ASSAYS | SYVA CO (US) | 1979-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230406874-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | PHAX, ALKBH1, JMJD6 | TOP2A 1501/4885NCF1 1722/4885KDM1A 1067/4885 |
| US-11021504-B2 | Functionalization and purification of molecules by reversible group exchange | PHAX, ALKBH1, JMJD6 | TOP2A 1501/4885NCF1 1722/4885KDM1A 1067/4885 |
| US-20210277043-A1 | FUNCTIONALIZATION AND PURIFICATION OF MOLECULES BY REVERSIBLE GROUP EXCHANGE | PHAX, ALKBH1, JMJD6 | TOP2A 1501/4885NCF1 1722/4885KDM1A 1067/4885 |
| US-12297221-B2 | Functionalization and purification of molecules by reversible group exchange | PHAX, ALKBH1, JMJD6 | TOP2A 1501/4885NCF1 1722/4885KDM1A 1067/4885 |
| US-11760772-B2 | Functionalization and purification of molecules by reversible group exchange | PHAX, ALKBH1, JMJD6 | TOP2A 1501/4885NCF1 1722/4885KDM1A 1067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.